Delivery Order SPE2DB20D3103-SPE2DB25FN5Q5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,952.65 to AmerisourceBergen Drug Corp for Dupixent 200 mg/1.14 ml pen injectors on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $36,944.08 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed price, competitively awarded delivery order represents a direct fulfillment under the company's existing pharmaceutical supply agreement with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency (DLA) awarded a $16,338.29 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors under a firm fixed-price contract type. This award, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-competitive delivery against an existing indefinite delivery contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,325.03 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply services under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,415.90 for Dupixent 300 mg/2 ml pen injectors under a firm fixed price contract. The award was issued on June 5, 2025, with an ultimate completion date of June 6, 2025. This non-competitive delivery order represents a continuation of pharmaceutical supply fulfillment to support federal medical procurement needs, with performance occurring at the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $42,536.47 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on May 28, 2025. This firm fixed price contract, with an ultimate completion date of May 29, 2025, represents a competitive award with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and...
- The Defense Logistics Agency awarded a $29,850.86 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors. The contract, designated as a firm fixed price delivery order with an ultimate completion date of July 28, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established...
- The Defense Logistics Agency awarded a delivery order valued at $21,198.66 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of pharmaceutical supply support to federal healthcare systems. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $20,876.59 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract supporting the federal government's pharmaceutical supply chain. The contract will be performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a $15,755.68 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injections. This is a firm fixed price, competitively awarded contract with a completion date of July 1, 2025, and represents a child order under a larger vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FN5Q5Delivery Order
The Defense Logistics Agency awarded a $27,537.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors on April 23, 2025, with completion scheduled for April 24, 2025. This non-compete delivery order represents a pharmaceutical supply transaction under the company's existing contract vehicle with DLA. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor supporting federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical supplies to support military healthcare programs worldwide. As a competitively awarded prime contractor, AmerisourceBergen Drug Corp continues to serve critical federal customers including the Defense Health Agency and U.S. Coast Guard through this flexible contracting mechanism that accommodates diverse pharmaceutical and medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.5k | 4/23/25 |